Stocks · US
CVS
XNYS
CVS HEALTH CORPORATION
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E22.76x
P/B1.40x
P/S0.27x
EPS$3.82
ROE6.14%
ROA1.93%
Dividend yield3.07%
EV/EBITDA10.03x
Debt/Equity0.77
Free cash flow$11.8B
Returns and 52-week range
1W-0.77%
1M-10.66%
3M-17.27%
6M+10.50%
1Y+11.54%
YTD+7.86%
52W high$110.68
52W low$69.51
From 52W high-21.91%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 메드트로닉 | $112.5B | 21.51 | 2.24 | -7.52% |
| 스트라이커 | $109.4B | 29.34 | 4.56 | -8.22% |
| Bristol-Myers Squibb Co. | $120.1B | 12.94 | 5.38 | -10.82% |
| 매케손 | $106.7B | 23.24 | — | +1.51% |
| 인튜이티브 서지컬 | $143.6B | 45.75 | 7.90 | +10.38% |
| 엘리밴스 헬스 | $85.6B | 17.24 | 1.91 | -1.82% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.